NCT04969666View on ClinicalTrials.gov

A Phase II, Repeat Single Oral Dose Study of IPED2015 in Healthy Male Subjects With Erectile Dysfunction

PHASE2UnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 4, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

November 30, 2022

Conditions
Erectile Dysfunction
Interventions
DRUG

IPED2015

Active treatment

DRUG

Placebo

Placebo

Sponsors

Lead Sponsor

Initiator Pharma
All Listed Sponsors
lead

Initiator Pharma

INDUSTRY